Drug intelligence / Profile preview

IsoDent Paro Strong

Development stage: Unknown
Lead developer: IsoDent
Modality: Small Molecules
Administration: Topical

Overview

**IsoDent Paro Strong** is a CE-marked topical oral-care medical-device mouthwash manufactured by IsoDent for advanced periodontal-support-tissue problems, including persistent gingival inflammation with tooth mobility, and for peri-implant mucosal inflammation. It contains the proprietary pro-resolving lipid mediator formulation NCD-1001, identified in product materials as lipoxin A4 methyl ester, alongside xylitol and erythritol. The product is intended to support resolution of oral inflammation and local tissue regeneration through tissue-modulation mechanisms rather than antimicrobial activity; it is used as an adjunct to professional dental care. ([isodent.fi](https://isodent.fi/en/product/isodent-paro-en/))

Brand names: IsoDent Paro StrongParo Strong

Beyond the preview

Go deeper on IsoDent Paro Strong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IsoDent Paro Strong.

Explore the full profile